Analytical Data
-
Gene name
RP9
- Application
-
Alternative Names
RP9;Retinitis pigmentosa 9 Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TA86
-
Expression Region
1-155aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSSRPGR EDVGAAGARR PREPPEQELQ RRREQKRRRH DAQQLQQLKH LESFYEKPPP GLIKEDETKP EDCIPDVPGN EHAREFLAHA PTKGLWMPLG KEVKVMQCWR CKRYGHRTGD KECPFFIKGN QKLEQFRVAH EDPMYDIIRD NKRHEKDV
-
Molecular Weight
21 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RP9 recombinant protein has garnered significant attention in recent years due to its potential implications in understanding various biological processes and disease mechanisms. This protein, associated with the retinitis pigmentosa (RP) pathology, is implicated in the degeneration of photoreceptor cells, leading to progressive vision loss. Research into RP9 aims to elucidate its role in the molecular signaling pathways involved in retinal health, as well as its interactions with other proteins crucial for cellular function. The exploration of RP9 is particularly relevant given the increasing prevalence of genetic retinal diseases and the urgent need for developing therapeutic strategies. Recombinant RP9 produced through advanced biotechnological techniques allows for in-depth functional studies and could pave the way for innovative approaches in gene therapy. By enhancing our understanding of the structure-function relationships of RP9, scientists hope to identify potential targets for intervention that could halt or reverse the effects of retinitis pigmentosa and potentially other related retinal disorders. This research not only contributes to the fundamental understanding of retinal biology but also holds promise for the development of novel therapeutic avenues that could significantly improve the quality of life for affected individuals.
